Last reviewed · How we verify

NCT03966196: OXYMETRE

Validation and Characterization of Signal Decrease on an Oximeter in COPD (They Have Chronic Obstructive Pulmonary Disease) Patients During Deep Inhalation (

Completed NA Last updated 29 May 2019
What this trial tests

NA trial testing Measurements of oxygen saturation and finger pressure during deep inspiration in Pulmonary Disease in 12 participants. Completed in 10 May 2019.

Timeline
11 February 2019
Primary endpoint
10 May 2019
10 May 2019

Quick facts

Lead sponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment12
Start date11 February 2019
Primary completion10 May 2019
Estimated completion10 May 2019
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain — full company profile →

Who can join

18 and older, any sex, with Pulmonary Disease or Copd. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective is to verify that there is a decrease in the pulsed oxygen saturation with the digital sensor. That is, the drop in oxygen saturation in COPD patients during inhalation is real and not due to an artifact of the measuring tool, because oximeters need a quality pulsatile signal to properly measure oxygen saturation

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pulmonary Disease

Currently open trials in the same condition.

Other Cliniques universitaires Saint-Luc- Université Catholique de Louvain trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03966196.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing